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SUMOylation is a relevant protein post-translational mod-
ification in eukaryotes. The C terminus of proteolytically
activated small ubiquitin-like modifier (SUMO) is cova-
lently linked to a lysine residue of the target protein by an
isopeptide bond, through a mechanism that includes an
E1-activating enzyme, an E2-conjugating enzyme, and
transfer to the target, sometimes with the assistance of a
ligase. The modification is reversed by a protease, also
responsible for SUMO maturation. A number of proteins
have been identified as SUMO targets, participating in the
regulation of cell cycle progression, transcription, trans-
lation, ubiquitination, and DNA repair. In this study, we
report that orthologous genes corresponding to the
SUMOylation pathway are present in the etiological agent
of Chagas disease, Trypanosoma cruzi. Furthermore, the
SUMOylation system is functionally active in this proto-
zoan parasite, having the requirements for SUMO matu-
ration and conjugation. Immunofluorescence analysis
showed that T. cruzi SUMO (TcSUMO) is predominantly
found in the nucleus. To identify SUMOylation targets and
get an insight into their physiological roles we generated
transfectant T. cruzi epimastigote lines expressing a dou-
ble-tagged T. cruzi SUMO, and SUMOylated proteins were
enriched by tandem affinity chromatography. By two-di-
mensional liquid chromatography-mass spectrometry a
total of 236 proteins with diverse biological functions were
identified as potential T. cruzi SUMO targets. Of these,
metacaspase-3 was biochemically validated as a bona
fide SUMOylation substrate. Proteomic studies in other
organisms have reported that orthologs of putative T.
cruzi SUMOylated proteins are similarly modified, indicat-
ing conserved functions for protein SUMOylation in this
early divergent eukaryote. Molecular & Cellular Pro-
teomics 10: 10.1074/mcp.M110.007369, 1–13, 2011.
Post-translational modification of proteins with ubiquitin
(Ub)1 or ubiquitin-like modifiers (Ubls) has emerged as an
important intracellular signaling event (1). SUMOylation in-
volves the covalent attachment of the Small Ubiquitin-like
Modifier (SUMO) to target proteins. SUMO is initially synthe-
sized as a precursor that is proteolytically processed at the C
terminus exposing a glycine residue which is subsequently
linked to an internal lysine residue of the substrate protein
through the concerted action of E1-activating and E2-conju-
gating enzymes, and eventually an E3-ligase enzyme (2).
SUMO has been shown to modulate activity, stability and/or
localization of the modified protein, likely by masking or add-
ing interaction surfaces or by inducing conformational
changes that result in altered protein-protein interactions (3).
In yeast and mammalian cells a prominent role for SUMO in
several important cellular processes, such as DNA replication
and repair, chromosome segregation, gene expression, and
nuclear trafficking was described (4, 5). Moreover, results
from large-scale proteomic studies provided a great number
of potential SUMO targets, suggesting that a broader spec-
trum of biological processes could be influenced by this post-
translational modification (6–17).
Trypanosomatids are flagellated protozoan organisms rep-
resenting some of the most primitive eukaryotes. Members of
this group include human parasites that cause a variety of
diseases: Trypanosoma cruzi is the causative agent of Chagas
disease, a chronic debilitating illness widespread in Central
and South America; T. brucei causes sleeping sickness in
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sub-Saharian Africa; and multiple species of Leishmania
cause cutaneous, mucocutaneous or visceral leishmaniasis in
South America, East Africa, Asia, and the Mediterranean re-
gion (http://www.who.int).
In T. cruzi, it has been demonstrated that Ub and Ubls are
important for parasite survival playing a significant role in the
adaptation to the different hosts. Ub controls protein fate by
triggering degradation through the 26S proteasome and the
Ubl Atg8 is involved in autophagosome biogenesis that recy-
cles cellular material. In the case of SUMO studies performed
in T. brucei have shown that SUMO is essential in cell cycle
regulation in procyclic and bloodstream forms (18, 19). How-
ever, the SUMOylation system has not been characterized yet
at the molecular level nor have the targets of SUMO been
identified in any Trypanosomatid.
In this work, we present the identification of the major
components of the SUMO pathway in T. cruzi, as well as
demonstrate the functionality of the system in this parasite.
We designed a purification scheme involving two affinity chro-
matography steps and obtained an enriched fraction of
SUMOylated proteins from transgenic parasites expressing a
tagged version of T. cruzi SUMO (TcSUMO). We identified a
number of proteins present in this sample by liquid chroma-
tography-tandem mass spectrometry (LC-MS/MS). These re-
sults suggest the involvement of SUMOylation in a broad
spectrum of biological processes, either well conserved
among eukaryotes or distinctive of these Trypanosomatids.
Finally, we confirmed that T. cruzi metacaspase-3 is SUMO-
ylated in vivo, thus being a novel bona fide target.
EXPERIMENTAL PROCEDURES
Parasites—The different life-cycle forms (epimastigote, metacyclic
trypomastigote, cell-derived trypomastigote, and amastigote) of T.
cruzi CL Brener strain were cultured in vitro. Briefly, epimastigotes
were grown axenically in a medium containing brain-heart infusion-
tryptose medium and fetal calf serum (BHT) as described (20). Meta-
cyclic trypomastigotes were obtained by spontaneous differentiation
of epimastigotes at 28 °C, followed by purification by DEAE-cellulose
chromatography (21). Amastigotes and trypomastigotes were ob-
tained by infection of Vero cell monolayers with trypomastigotes (22).
SUMO-transfectant epimastigotes were maintained in BHT contain-
ing 0.1 mg/ml G418.
In Silico Analysis—BLAST searches were performed against T.
cruzi genome database (http://www.genedb.org) using the main com-
ponents of the SUMO pathway from S. cerevisiae and human as
queries. The assignment of orthology was based on the number of the
E-values in the BLAST output (103) and in the presence of key
amino acid residues or domains. Sequences were aligned with
ClustalW (http://www.ebi.ac.uk/Tools/clustalw2/index.html) and oc-
casionally refined manually.
Recombinant TcSUMO Protein Expression and Antibody Produc-
tion—The sequence corresponding to Tc00.1047053511661.50
(hereafter referred to as TcSUMO) was amplified by PCR using as
template T. cruzi CL Brener genomic DNA, with primers flanked by
NheI and BamHI restriction sites. The resulting DNA fragment was
gel-purified by Qiaquick columns (Qiagen, Valencia, CA), cloned into
pGEM-T Easy vector (Promega, Madison, WI), and completely se-
quenced (Macrogen, Seoul, Korea). Inserts were liberated with the
appropriate restriction enzymes (New England Biolabs, Ipswich, MA)
and cloned into the same sites of pET-28a() bacterial expression
vector (Novagen, EMD Chemicals, San Diego, CA) generating pET28-
His6-TcSUMO-His6 for the expression of double (N- and C-terminal)
His-tagged protein. The primers used in this work are listed at the end
of Experimental Procedures section.
Plasmid construct pET28-His6-TcSUMO-His6 was used to trans-
form Escherichia coli Bl21 - Codon Plus (Stratagene, La Jolla, CA).
Cultures were induced with 0.5 mM isopropyl -D-thiogalactoside for
4 h at 37 °C, harvested by centrifugation at 3000  g for 10 min and
pellets were frozen. Cells were thawed at 4 °C and lysed with Tris-
buffered saline (TBS) (50 mM Tris-HCl pH 7.6, 150 mM NaCl) contain-
ing 0.1% Triton X-100 and 0.1 mg/ml lysozyme. After sonication, cell
debris was removed by centrifugation at 20,000  g for 25 min at 4 °C
and the supernatant was applied to a fast flow Ni-NTA column (Am-
ersham Biosciences, GE Healthcare), pre-equilibrated with binding
buffer (50 mM Tris-HCl pH 7.6, 500 mM NaCl). The column was first
washed with binding buffer, then with the same buffer supplemented
with 30 mM imidazole, and finally proteins were eluted with binding
buffer containing 300 mM imidazole. Eluate containing the recombi-
nant protein was pooled and buffer was exchanged to phosphate-
buffered saline (PBS) (10 mM Na2HPO4, 150 mM NaCl, pH 7.2) using
a PD-10 column (Amersham Biosciences, GE Healthcare).
Polyclonal rabbit and mouse antibodies were raised by immuniza-
tion with purified recombinant TcSUMO in PBS using standard pro-
tocols (23). The first immunization was performed using 200 g (for
rabbits) or 20 g (for mice) of the protein with complete Freund’s
adjuvant, followed by three boosters using one quarter of the amount
of protein with incomplete adjuvant. The boosters were given every 21
days for rabbits and every 14 days for mice. Ten days after the last
booster the animals were bled and the antisera were obtained.
Generation of TcSUMO Transfectant Epimastigotes—A full-length
version of TcSUMO (construct 1) was tagged at the N terminus with
a 6  His-HA tag and at the C terminus with a FLAG (DYKDHDGD)
epitope by performing two consecutive rounds of PCR. In a first PCR,
TcSUMO was amplified from the clone in pGEM-T Easy vector using
a forward primer that introduced the HA tag upstream the first triplet
within the open reading frame (HA sense primer) and a reverse primer
that introduced the FLAG epitope and XhoI restriction site (FLAG
reverse primer). The second PCR was performed using the product of
the first reaction as a template, the same reverse primer and a forward
primer encoding six histidine residues after the artificially added ATG
start codon and a SmaI site (His6 sense primer). Full-length version
of TcSUMO with alanine replacing the scissile glycine (construct 2)
was generated by site-directed mutagenesis using the Quick Change
site directed mutagenesis kit (Stratagene) and the mutation was ver-
ified by automatic DNA sequencing. TcSUMO mature form (construct
3), as well as TcSUMO nonconjugatable form (construct 4), were
amplified as explained for construct 1 except that no tag was added
at the C terminus (using reverse primers GG and GG for construct 3
and 4, respectively). The corresponding DNA fragments were com-
pletely sequenced and cloned into the pTex plasmid (24). These four
constructs were used to transfect T. cruzi epimastigotes as previously
described (25).
Tandem-affinity Purification of SUMO Conjugates—For standard
tandem-affinity purification (TAP), a 1-liter epimastigote T. cruzi cul-
ture was grown to a density of 5  107 cells per ml, which corre-
sponded approximately to 4 g of parasites. Cells were washed twice
in PBS and harvested by centrifugation at 1500  g for 5 min. Pellets
were frozen immediately in liquid nitrogen and kept at 80 °C until
use. This material was resuspended in 20 ml lysis buffer (50 mM
Tris-HCl pH 7.6, 0.5 M NaCl, 0.5% Nonidet P-40, 50 M TLCK, 2 mM
Iodoacetamide, 2 mM , phenylmethylsulfonyl fluoride) and incubated
for 15 min on ice. When necessary, DNA present in the sample was
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removed by the addition of 10 M DNase. Cell-free extracts were
obtained by centrifugation at 20,000  g for 30 min. The supernatant
was incubated with 3 ml slurry of Ni-NTA resin (Amersham Biosci-
ences, GE Healthcare) pre-equilibrated with binding buffer (50 mM
Tris-HCl pH 7.6, 500 mM NaCl) for 2 h at 4 °C. The resin was washed
3 times with 25 ml binding buffer and eluted with 5 ml binding buffer
containing 500 mM imidazole. Fractions containing protein were com-
bined and diluted twofold with buffer TBS containing 1% Nonidet
P-40. The sample was then mixed with 1 ml of anti-HA Affinity Matrix
(Roche) and incubated for 2 h at 4 °C. The matrix was washed with 10
ml of TBS containing 0.5% Nonidet P-40, packed in a column, and
the HA-tagged proteins were eluted with 1.5 ml of 50 mM Tris-HCl pH
7.6, 1% SDS. Finally proteins were precipitated with acetone 80%
during 24 h at 20 °C. The control preparation for this experiment
was prepared in the same manner, except that wild-type (nontrans-
fected) epimastigotes were used.
Liquid Chromatography-Tandem Mass Spectrometry Analysis (LC-
MS/MS)—Protein pellets were dissolved in 50 l 0.4 M NH4HCO3
containing 8 M urea and reduced with 5 mM dithiothreitol for 15 min at
50 °C. Reduced thiol groups were alkylated with 10 mM iodoacet-
amide for 30 min at room temperature, and diluted 8 fold with HPLC-
grade water. Samples were digested overnight with 6 g sequencing-
grade trypsin (Sigma-Aldrich), as described (26). After quenching the
reaction with 10 l formic acid, samples were desalted with C18
cartridges (100 mg, 1 ml, Supelco) and dried in a vacuum centrifuge.
Peptides were redissolved in 50 l 0.1% formic acid and subjected
(20 l) to two-dimensional LC-MS/MS analysis, using an Eksigent
1D-plus nanoLC coupled to a LTQ XL/ETD-MS (Thermo Fisher
Scientific), equipped at the front end with a TriVersa NanoMate
electrospray ionization nano-source (Advion). In this setup, pep-
tides are loaded onto a first-dimension strong cation exchange
column (5 l, Optimized Technologies) and the elution is achieved
by sequential injection (20 l each time) of increasing salt concen-
trations (0, 25, 50, 100, 200, and 500 mM NaCl in 5% acetonitrile
(ACN)/0.5% formic acid) through the autosampler. Eluting peptides
are then captured into one of the two C18-reverse phase trap
columns (1 cm, 75 m, Phenomenex Luna C18, 5 m) of the system
and washed extensively (130 min with 5% ACN/0.5% formic acid,
at 1.5 l/min) to remove the salt. In the next round, reverse-phase
(RP) chromatography is performed connected online to the mass
spectrometer; whereas a second step of strong cation exchange
elution is performed simultaneously through the second C18-RP
column, thus avoiding time gaps between runs and increasing the
capability and throughput of the system (ES Nakayasu, et al. un-
published data). The separation in the second C18-reverse phase
capillary column (20 cm, 75 m, Phenomenex Luna C18, 5 m) was
carried out using the following linear gradient: Solvent A: 5% ACN/
0.1% formic acid; Solvent B: 80% ACN/0.1% formic acid, 5–40% B
in 200 min, 50–90% B in 1 min, 5 min in B, 90–5% B in 1 min, and
20 min in 5% B. The MS system was set to perform one full scan
(400–2000 m/z range) followed by MS/MS of the 10 most abundant
parent ions (isolation width  3.0 m/z; 35% normalized collision
energy). The dynamic exclusion was set to collect each parent ion
twice and subsequently excluding them for 30 s.
Protein Identification and Quantitative Analysis—The resulting
MS/MS spectra (800–3500 Da, minimum of 10 counts and 15 ions)
were converted to DTA files submitted to database search using
SEQUEST (Available in Bioworks 3.3.1, Thermo Fisher Scientific). The
database was comprised of T. cruzi, Bos taurus, human keratin, and
porcine trypsin sequences (all in correct and reverse orientations,
totaling 191,242 searched sequences), downloaded from GenBank
on September 29, 2009. Bos taurus contaminant proteins arise from
the bovine serum present in the culture medium. Epimastigote forms
of T. cruzi not only adsorb these proteins to their surfaces but also
take up large amounts of serum proteins and other nutrients to store
them in organelles called reservosomes (27). Bovine proteins, human
keratin, and porcine trypsin were filtered out before assembling the
last version of the identification tables (supplemental Tables S1
and S2).
The parameters for database search were: (1) 2.0 and 1.0 Da for
peptide- and fragment-mass tolerance; (2) trypsin cleavage at both
termini and one missed cleavage allowed; and (3) methionine oxidation
and cysteine carbamidomethylation as variable and fixed modifications,
respectively. The Sequest results were filtered using Bioworks 3.3.1
with delta correlation (dCN)  0.05; peptide probability  0.05; and
cross correlation (Xcorr)  1.5, 2.0, and 2.5 for singly, doubly and triply
charged peptides, respectively. After filtering, peptide sequences were
assembled into protein sequences and the redundant proteins into
protein groups, using an in-house Perl script (28). The results were
further filtered with a sum of peptide Xcorr  6, at least two unique
peptides and protein probability  1E-3, which provided a false-discov-
ery rate for protein identification of 0.7%. Differential protein expression
analysis spectral count data were analyzed by QSpec, a software for
differential protein expression (29). QSpec employs Poisson distribution
to model the spectral count data and computes Bayes factor, equiva-
lent to the likelihood ratio of differential expression for each protein.
Large Bayes factors indicate stronger evidence of differential expres-
sion. Following the likelihood ratio computation, QSpec estimates the
false discovery rates at various thresholds using an empirical Bayes
approach (29). Spectra of peptides shared by more than one protein
were also included in our analysis. We only considered as a SUMO-
ylated candidate proteins with a QSpec false-discovery rate  0.01 and
at least twice more abundance.
Metacaspase-3 Pull-Down Assay—For inducible expression of
metacaspase-3 in the parasite, we first generated a cell line express-
ing T7 RNA polymerase and Tet repressor genes by transfecting
epimastigotes with the plasmid pLew13 using the aforementioned
electroporation method. Stable transfectants were selected and rou-
tinely grown in brain-heart-tryptose (BHT) medium supplemented
with 10% inactivated fetal calf serum and 100 g/ml G418 (Invitro-
gen). This parental cell line was then transfected with pTcINDEX
construct (30) carrying the metacaspase-3 gene fused to a triple-
FLAG epitope, and transgenic parasites were obtained after selection
with 100 g/ml G418 and 200 g/ml hygromycin B (Calbiochem).
Epimastigote cultures were grown to reach a cell density of 5–10 
106 parasites/ml and protein expression was induced by the addition
of 10 g/ml tetracycline for 3 days. Epimastigotes (1  109 cells) were
harvested by centrifugation at 1000  g for 5 min, washed in PBS and
lysed on ice by incubation in buffer TBS supplemented with 1%
Nonidet P-40 and protease inhibitors (50 M TLCK, 2 mM iodoacet-
amide) (TBS/Nonidet P-40/PI). The insoluble material was removed by
centrifugation at 20,000  g for 15 min, and the supernatant was
incubated with 50 l anti-FLAG M2 Agarose Affinity Gel (Sigma-
Aldrich) pre-equilibrated with TBS/Nonidet P-40/PI. The beads were
washed five times with TBS/Nonidet P-40/PI and proteins were eluted
with Laemmli’s sample buffer.
Electrophoresis and Western blotting—Proteins were separated by
SDS-PAGE and transferred to a nitrocellulose membrane for probing.
TcSUMO was detected using the polyclonal antibodies raised in
rabbits against the recombinant purified protein diluted 1:300. The HA
tag was detected using a high-affinity rat monoclonal antibody
(Roche) diluted 1:1000. The FLAG epitope was detected using anti-
FLAG M2 mouse monoclonal antibody (Sigma-Aldrich) diluted
1:1000. Horseradish peroxidase-conjugated goat anti-rabbit (Sigma),
goat anti-rat (Calbiochem, San Diego, CA), or goat anti-mouse (Cal-
biochem) secondary antibody (1:5000 dilution) was detected by
chemiluminescence using SuperSignal West Pico Chemiluminescent
Substrate (Pierce, Rockford, IL).
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Immunofluorescence Studies—Parasites were fixed with 4% para-
formaldehyde in PBS for 15 min and adhered to glass slides as
described (25). Coverslides were saturated in the blocking buffer (2%
bovine serum albumin, 0.1% saponin in PBS) containing 3% goat
serum, for 30 min and incubated for 1 h with the primary antibody
diluted in the blocking buffer. Parasites were washed with PBS and
incubated with the appropriate secondary antibody diluted in the
blocking buffer for 1 h. After extensive washing with PBS, coverslides
were mounted using FluorSaveTM reagent (Calbiochem) containing 5
g/ml DAPI. The primary antibodies used were mouse anti-TcSUMO
polyclonal antibodies (1:100 dilution) and rat anti-HA high affinity
monoclonal antibodies (Roche) (1:1000 dilution). The secondary an-
tibodies used were AlexaFluor 546-conjugated goat anti-mouse or
anti-rat immunoglobulins (Molecular Probes) diluted 1:1000. Slides
were examined on a Nikon Eclipse E600 fluorescence microscope
and image capture was performed by a Spot RT Slider Model
No.2.3.1 digital camera (Diagnostic Instruments).
Oligonucleotides—The following primers were used: for pET28-
His6-TcSUMO-His6 construct, sense primer GCTAGCATGGAGGAG-
AATCATGCAAATG and antisense primer GGATCCCAAAACGTGTT-
CCCGCCTGTC; for pTex constructs HA sense primer TACCCATA-
CGATGTTCCAGATTACGCTATGGAGGAGATTCATGCAAATG and
Hisx6 sense primer CCCGGGATGCACCACCACCACCACCACTACC-
CATACGATGTTCC, FLAG reverse primer CTCGAGTCAATCACCGT-
CATGGTCTTTGTAGTCGAGTGCGGCCGCAACCTTG, GG reverse
primer CTCGAGTCATGTCTGCTCAACCATGG and GG reverse
primer CTCGAGTCACCCGCCTGTCTGCTC. For site directed mu-
tagenesis of the Gly residue, sense primer GGTTGAGCAGACAGGC-
GcGAACACGTTTTGGGATC and antisense primer GATCCCA-
AAACGTGTTCgCGCCTGTCTGCTCAACC.
RESULTS
Identification of SUMO Pathway Components in the T. cruzi
Genome—In order to identify the core components of the
SUMOylation pathway in T. cruzi we performed BLAST
searches against the genome database (http://www.genedb.
org) using the corresponding proteins from Saccharomyces
cerevisiae and Homo sapiens as queries. The predicted gene
orthologs are shown in Table I. T. cruzi possesses a single
SUMO paralog which displays 41% and 39–42% sequence
identity to S. cerevisiae Smt3p and the three human SUMOs
(designated SUMO-1, SUMO-2, and SUMO-3), respectively.
The amino acid sequence alignment (Fig. 1) shows that, al-
though having highly variable N-terminal extensions, these
proteins exhibit an overall sequence similarity including a
conserved diglycine motif, critical for SUMO maturation and
conjugation (31). Furthermore, TcSUMO shares with Smt3p,
SUMO-2 and SUMO-3 a Lys residue lying within a SUMO-
ylation consensus site (32) meaning that TcSUMO has the
potential to form poly-SUMO chains.
SUMO is synthesized as a precursor form that is post-
translationally cleaved to expose the C-terminal diglycine mo-
tif. Mature SUMO becomes covalently conjugated to other
proteins through an isopeptide linkage between its C terminus
and the -amino group of a targeted lysine residue in the
substrate protein. Ubiquitin like protein proteases/Sentrin
specific proteases (Ulps/SENPs) mediate both processing
and deconjugation of SUMO (33–35). Ulps/SENPs share a
C-terminal cysteine protease domain of 250 amino acids
containing the catalytic triad His-Asp-Cys, whereas the N-ter-
minal domain is not well conserved, diverging in primary
sequence and size (36, 37). Based on local sequence align-
ment of the catalytic domain T. cruzi Ulp/SENP can be as-
signed to Ulp group 1 (supplemental Fig. S1).
SUMO is activated by a single heterodimeric E1 enzyme.
The putative E1a and E1b subunits of T. cruzi have, as de-
scribed for yeast and mammals (38, 39), a multidomain archi-
tecture that includes an adenylation domain that binds ATP-
Mg2 and SUMO, a C-terminal ubiquitin-fold domain that
recruits E2 for thioester transfer, and a catalytic domain that
contains the active site cysteine in the E1b subunit
(supplemental Fig. S2). A single SUMO-conjugating enzyme
was also detected in the genome of T. cruzi and a highly
conserved cysteine residue could be inferred as responsible
to form the E2SUMO thioester adduct (suppleme-
ntal Fig. S3). Finally, based on sequence homology analysis a
number of potential SUMO ligases belonging only to the
SP-RING-type family were identified.
Analysis of SUMOylation Pattern in Life-cycle Stages of T.
cruzi—After bioinformatic analysis revealed that T. cruzi ge-
nome bears the genes encoding all components of the SUMO-
ylation system, we decided to study its functionality in the
parasite. We developed rabbit polyclonal anti-TcSUMO anti-
bodies against the recombinant protein (see Experimental Pro-
cedures) and used them to determine SUMO expression
throughout the parasite’s life-cycle by Western blot analysis.
TABLE I
Genes encoding components of the SUMOylation pathway in T. cruzi
Protein name GeneDB accesion number of haplotypes
SUMO Tc00.1047053507809.70 Tc00.1047053511661.50
E1 subunit a Tc00.1047053508177.100 Tc00.1047053511691.30
E1 subunit b Tc00.1047053509777.100 Tc00.1047053511655.69/
Tc00.1047053509117.10
E2 Tc00.1047053508741.280 Tc00.1047053503515.14
SUMO peptidase Tc00.1047053503407.20 Tc00.1047053505193.40
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Fig. 2A shows a typical SUMOylation pattern with several reac-
tive bands consistent with a range of proteins being conjugated
to SUMO. The faster-migrating double band, with apparent
molecular masses of 16 and 18 kDa, possibly corresponds to
the mature and precursor forms of free SUMO, respectively (Fig.
2A, bottom panel). Although their apparent molecular masses
do not match with their theoretical molecular masses (11.4 and
11.8 kDa, respectively), an anomalous electrophoretic behavior
has been reported for all SUMO proteins (31, 40). The high
relative molecular mass bands observed at the 40–100 kDa
range likely correspond to covalent adducts between SUMO
and a diverse set of target proteins. Therefore, SUMOylation
seems to be functional in the four major life cycle stages of the
parasite (Fig. 2A, top panel). Immunofluorescence analysis per-
formed with the same antibody on different forms of the parasite
showed that the subcellular distribution of endogenous Tc-
SUMO (free and conjugated) was predominantly nuclear, al-
though a less intense cytoplasmic signal could also be detected
(Fig. 2B). The results obtained with anti-TcSUMO polyclonal
antibodies on wild-type epimastigotes were further confirmed
by performing a similar analysis in transgenic epimastigotes
expressing an ectopic HA-tagged version of TcSUMO using
anti-HA monoclonal antibodies (see below).
Requirements for TcSUMO Processing and Conjuga-
tion—As we mentioned above, several authors have demon-
strated the major role that the conserved diglycine motif (GG)
plays in both, proteolytic maturation and conjugation of
SUMO. To test whether SUMO has an analogous requirement
in T. cruzi, we generated four stable epimastigote lines that
ectopically expressed different forms of TcSUMO. Constructs
are schematically summarized in Fig. 3A. In order to deter-
mine the requirements for SUMO processing in the parasite,
we first analyzed whole cell lysates from epimastigotes ex-
pressing full-length His6-HA-TcSUMO-FLAG (construct 1)
and the corresponding Gly104 to Ala mutant (construct 2) by
Western blot using monoclonal antibodies against both, HA
and FLAG tags. TcSUMO monomer in construct 1 was de-
tected as a single band reactive only with anti-HA but not with
anti-FLAG antibodies (Fig. 3B), suggesting a proteolytic event
at the C terminus of the protein that removes the FLAG
epitope. In construct 2, a single slower migrating band was
detected with both antibodies, meaning that the proteolytic
processing was inhibited when Gly104 was changed to Ala
(Fig. 3B). Therefore, we confirmed that the diglycine motif is
essential for maturation and found that almost all newly
synthesized TcSUMO was proteolytically processed to gen-
erate the mature form. Most of the activatable precursor
(construction 1) is likely activated by SENP, and does not
accumulate. The mutated precursor (construction 2), on the
other hand, accumulates. The double band of the mutated
SUMO precursor cannot be caused by the specific action of
SENP, and might be because of unspecific cleavage by SENP
itself, or other parasite proteinase.
With respect to conjugation, a Western blot analysis of
epimastigote lysates with anti-HA antibody was carried out,
looking for targets of SUMOylation (Fig. 3C). Using full-length
TcSUMO (already known to be processed) and mature
TcSUMO (constructs 1 and 3, respectively), the appearance
of high apparent molecular mass bands corresponding to
TcSUMO conjugated to targeted substrates was observed.
When mutated and truncated forms of TcSUMO (constructs 2
and 4, respectively), were tested, the formation of high appar-
ent molecular mass adducts was abolished. These results
suggested that TcSUMO was conjugated through its carboxy-
end diglycine motif.
The subcellular localization of SUMO in cell lines expressing
the constructs was studied by immunofluorescence. Cells
expressing the conjugable forms of TcSUMO (constructs 1
FIG. 1. Alignment of SUMO proteins from S. cerevisiae and human with the deduced amino acid sequence of T. cruzi SUMO
haplotypes. Identical and conserved amino acids are shaded in black and gray, respectively. Shade of gray depends upon number of residues
conserved. The carboxyl-terminal glycine cleaved by the Ulps/SENPs is marked with an arrowhead and the internal SUMOylation site is
underlined. Accession numbers or GeneDB systematic names are: T. cruzi, Tc00.1047053507809.70 and Tc00.1047053511661.50; S.
cerevisiae, NP_010798; Human - SUMO-1, NP_001005781.1; SUMO-2, NP_008868.3; SUMO-3, NP_008867.2.
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and 3) displayed a predominantly nuclear and less intense
cytoplasmic labeling, in contrast to epimastigotes expressing
nonconjugatable forms of TcSUMO (constructs 2 and 4)
where labeling was uniform throughout the cell. Parasites
ectopically expressing precursor or mature TcSUMO (con-
struct 1 and 3 in Fig. 3D) showed a similar distribution to
endogenous TcSUMO (Fig. 2B).
Tandem-affinity Purification and Identification of Potential
SUMO Targets—The above described cell line ectopically ex-
pressing a tagged version of full-length TcSUMO (construct 1)
was used as starting material for the isolation and identification
of SUMOylation targets in a large-scale proteomic study. SU-
MOylated proteins were enriched after two TAP steps, a Ni-NTA
affinity column followed by an anti-HA affinity column. A mock
purification from a wild-type cell line was also performed as
control. Test and mock eluates were analyzed by silver staining
and they both showed an identical pattern of bands except for
the free TcSUMO. (Fig. 4A, left panel). Although few bands were
detected by this technique, the sample was clearly enriched in
SUMOylated proteins that were visualized by Western blot us-
ing anti-HA antibodies (Fig. 4A, right panel). Each protein mix-
ture was prepared in triplicates, digested with trypsin and ana-
lyzed by online two-dimensional liquid chromatography-tandem
mass spectrometry (2D LC-MS/MS). Peptide sequences and
their corresponding proteins were identified by searching the
spectra against T. cruzi and possible contaminant (non-T. cruzi)
protein databases using the SEQUEST algorithm (see Experi-
mental Procedures section).
The large number of background proteins (nonspecific
binders) that is cocaptured during tandem-affinity purification
of SUMOylated proteins is a well-documented phenomenon
(12, 41, 42). Thus, the identification of potential SUMOylated
candidates needs to be done by quantitative analysis com-
paring test with mock affinity purification. In our analysis, over
two thousand (2686) nonredundant proteins were identified in
both test and mock eluates out of a total of 7178 protein hits
(supplementary Tables S1 and S2). Next, to state the proteins
that were enriched in the test tandem-affinity purifications, we
performed a quantification using the spectral count approach.
The enriched protein hits were determined by statistical anal-
ysis using QSpec (supplementary Table S3). After carrying out
the comparison between test and mock control samples, a
group of 236 proteins that were more abundant in the test
sample was identified. The complete list of proteins is given in
supplementary Table S4, including annotation ID of gene
alleles. Our triplicate data allowed us to determine the repro-
ducibility, i.e. interaction specificity in test and mock tandem-
affinity purifications (supplementary Table S5). For example, all
our selection of SUMOylation targets demonstrated the replica-
tion in two or more test affinity purifications, but only few were
present in mock experiments. By contrast, in the next 236
potential targets that we did not consider as significant evi-
dence, most targets showed replication in two or three test
affinity purifications, but the majority of them were also present
in all three mock purifications. The remainder of data showed
relatively worse replication rates even in test purifications, let
FIG. 2. Analysis of SUMOylation pattern in life-cycle stages of T. cruzi. A, Total cell lysates of 2  107 epimastigotes (E), metacyclic
trypomastigotes (M), amastigotes (A), and cell-derived trypomastigotes (T) were electrophoresed on SDS-PAGE 7.5% (upper panel) and 15%
(lower panel), transferred to nitrocellulose membranes and probed with anti-TcSUMO polyclonal antibodies. Precursor and mature forms of
SUMO are depicted with a filled or empty arrowhead, respectively. B, Indirect immunofluorescence study of the different forms of the parasite
using anti-TcSUMO polyclonal antibodies and AlexaFluor 546-conjugated goat anti-mouse secondary antibody. Nuclear and kinetoplast DNA
were visualized by DAPI staining. The SUMO fluorescence image (red) has been merged with the corresponding DAPI staining (blue), and the
resulting merged images are shown.
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alone the sporadic patterns in mock experiments. This clearly
shows that our selection reflects the most representative frac-
tion of replicated SUMOylation targets in the current data.
Manual inspection of the data allowed us to provide func-
tional annotation for 152 proteins, whereas the rest of them
remained as hypothetical proteins. In the group of proteins
with functional annotation we found that almost 40% had at
least one typical consensus site of SUMOylation (SUMOsp
2.0) (43) and 35 proteins have been previously identified in
proteomic studies of SUMOylation in other organisms. More-
FIG. 3. A, Schematic representation of SUMO constructs in the T. cruzi expression vector pTEX. Construct 1 corresponds to TcSUMO
precursor protein, containing the conserved diglycine motif, tagged at the N- and C termini with His6-HA and FLAG, respectively. Construct
2 is identical to construct 1 except that the scissile glycine was mutated to alanine. Construct 3 represents TcSUMO mature form tagged only
at the N terminus with His6-HA and construct 4 is similar to construct 3 but lacks the “GG” motif. B, Western blot analysis of in vivo SUMO
maturation. Lysates from stable cell lines (5  106 parasites/lane) expressing constructs 1 and 2 were electrophoresed on SDS-PAGE 15% and
transferred to nitrocellulose membranes. Blots were probed with anti-HA, anti-FLAG or anti-SUMO antibodies and proteins were visualized by
chemiluminescence. SUMO unprocessed and processed forms are marked with a black and a white arrowhead, respectively. C, Western blot
analysis of in vivo SUMO conjugation. Lysates from stable cell lines (2  107 parasites/lane) expressing all four constructs were electrophore-
sed on SDS-PAGE 7.5% (up) and 15% (down) and transferred to nitrocellulose membranes. Blots were probed with anti-HA antibodies and
proteins were visualized by chemiluminescence. A number of high apparent molecular mass protein bands likely corresponding to SUMO
conjugates are shown in the upper blot. SUMO unprocessed and processed forms are marked with a black and a white arrowhead, respectively
in the lower blot. D, Epimastigotes transfected with the different HA-tagged TcSUMO constructs were analyzed by immunofluorescence using
rat anti-HA monoclonal antibody and AlexaFluor 546-conjugated goat anti-rat secondary antibody. Nuclear and kinetoplast DNA were
visualized by DAPI staining. The HA fluorescence image (red) has been merged with the corresponding DAPI staining (blue), and the resulting
merged images are shown.
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over, some of them have been clearly demonstrated to be
SUMOylated by biochemical approaches as discussed below.
With respect to annotation, proteins were categorized ac-
cording to the biological processes in which they participate
and a representative distribution is shown in Fig. 4B and Table
II. We found proteins involved in classical nuclear processes
that have been described to be regulated by SUMO, such as
DNA replication and repair, chromatin remodeling, mRNA me-
tabolism, ribosome biogenesis, and nuclear transport. In ad-
dition, we found well represented cytoplasmic and mitochon-
drial proteins involved in biological processes, such as lipid
metabolism, carbohydrate metabolism, RNA editing, and in-
tracellular protein transport. Recently, these processes have
also been proposed to be associated with SUMOylation (44),
providing further confidence to our proteomic results.
Metacaspase-3 is a Substrate of SUMOylation—In the list of
potential targets of SUMOylation, metacaspase-3 drew our
attention because it has been the subject of studies in our
laboratory (25). Therefore, we decided to perform additional
experiments to validate it as a SUMO target. To achieve this
goal, we have generated trypanosome cell lines expressing a
version of metacaspase-3 tagged with a triple FLAG epitope
at the C terminus, under the control of a tetracycline-regu-
lated promoter using pTcINDEX vector (30) (see Experimental
Procedures section). We confirmed the expression of epitope-
tagged metacaspase-3 by Western blot after inducing with
tetracycline (data not shown). Then, we performed a purifica-
tion of tagged-metacaspase-3 using anti-FLAG affinity col-
umn and eluted the bound proteins with Laemmli’s sample
buffer. Western blot analysis of the eluate with anti-FLAG
antibodies showed a strong band at the expected apparent
molecular mass for metacaspase-3 and an extra band with
higher molecular weight. This band was also reactive when
the eluate was analyzed with anti-TcSUMO antibodies. These
results showed that a minor fraction of metacaspase-3 was
SUMOylated (Fig. 5), thus validating this protein as a bona fide
SUMOylation target.
DISCUSSION
A bioinformatic analysis of the T. cruzi genome unambigu-
ously confirmed the existence of all essential genes of the
SUMO conjugation and deconjugation pathway. Western blot
analysis of total parasite homogenates using anti-TcSUMO
polyclonal antibodies showed a band pattern compatible with
a classical SUMOylation pattern. The presence of several
slower migrating bands in addition to the SUMO precursor
and mature bands support the existence of a functional
SUMOylation system and multiple SUMO targets in the four
major life cycle stages of the parasite. Although a number of
the bands observed are common to all stages, there are some
bands which are not. This might be because of a stage-
specific expression or a stage-specific SUMOylation of the
target protein. The functionality of the system was further
confirmed when an HA-tagged version of TcSUMO was ec-
topically overexpressed in the parasite. Analysis of the trans-
fected cell line showed that although the bulk of the SUMO
protein remained unconjugated, high apparent molecular mass
adducts were still detected. This suggests that SUMOylation is
a tightly regulated process where only a small fraction of a target
protein is modified with SUMO at any given time.
Fig. 2A shows the endogenous SUMOylation pattern, in par-
asite extracts using a polyclonal antibody raised against a pu-
rified recombinant TcSUMO. Fig. 3C, on the other hand, shows
the SUMOylation pattern in extracts of parasites expressing an
ectopic SUMO containing His-HA tags in the N terminus, ob-
tained with an anti-HA monoclonal antibody. It is likely that the
greater number of bands in Fig. 3C is caused by the high affinity
of the commercial anti-HA antibody, which would improve the
detection of the conjugates, as compared with Fig. 2A.
Analysis by Western blotting, using anti-SUMO antibodies,
of the expression of endogenous SUMO suggests that the
majority of SUMO is present in conjugates and the remaining
SUMO is free (precursor and mature forms). A similar analysis
of epimastigotes transfected with tagged SUMO, using
FIG. 4. A, Tandem affinity purification of SUMO targets. Starting material correspond to transgenic epimastigotes (S, sample) expressing
the SUMO precursor form tagged at the N terminus with His6-HA (construct 1, see Fig. 3) or mock T. cruzi wild-type epimastigotes (C, control).
Samples collected at the two different purification stages (Ni2-NTA and anti-HA-agarose) were resolved in 10% SDS-PAGE and silver stained
(left) or blotted and probed with anti-HA antibodies (right). The arrowhead denotes free SUMO and the asterisk indicates the immunoglobulin
light chain. B, Pie chart summarizing the functional classification of the proteins identified by the proteomic analysis of the purified proteins.
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anti-HA antibodies, suggests that in this case a smaller pro-
portion of SUMO is present in conjugates whereas a greater
amount appears as free form. Analysis of the overexpression
of ectopic SUMO using the anti-SUMO serum suggests that
overexpression results in an increase of about fivefold as
compared with the endogenous protein. Analysis by immuno-
fluorescence of the endogenous SUMO, as well as the con-
jugatable forms of tagged TcSUMO, suggests that in both
TABLE II
Functional categorization of identified SUMOylated protein candidates
Biological Process Protein Name
Sumoylation SUMO
DNA Replication and Repair








RNA helicase DEAD/H RNA helicase, RNA helicase
mRNA metabolism TRRM1, PUF6, RNAse, RBP, PABP1, hnRNPH, U5 snRNP-specific 40 kDa protein
RNA editing RNA editing endoribonuclease and ligase, oligoU binding protein
tRNA Metabolism PseudoU Synthase I, Tyr, Val, Trp and Queuine tRNA Synthetases








Translation Initiation IF-2, eIF4a, SUI1
Translation Elongation EF-2
Translation Termination eRF1 and eRF3
Protein Folding -Glucosidase II, DNAJ protein and Cyclophilin
Intracellular Protein Transport
Vesicle Mediated Transport Sec1, Sec23A, Rab7, Rab-GAP, coatomer-, -adaptin 3
Vacuolar Transport Vps26, Vps16,
Mitochondrial Transport Mitochondrial carrier
Golgi Organization COG2
Microtubule Motor Activity Kinesin, MCAK-like kinesin
Protein Targeting to Membrane SRP, SRPR
Protein Catabolism
Proteases Peptidase M1, M16, M41and M67, metacaspase, cruzipain, oligopeptidase B, calpain-like
Ubiquitination Cycle Ub hydrolase and Ub-protein ligase
Carbohydrate Metabolism UDPGP, DAK1, Enolase, TKT, PGK, 6PF2K
Intermediate Metabolism Pyr dh E1, 2-oxoacid dh (E1, E2 and E3), Iso dh
Lipids Metabolism
Fatty Acid Metabolism Thiolase, 2,4-dienoyl-Coa reductase, 3HCDH, fatty acid desaturase, Ac-CoA Synthetase
Coenzyme A Biosynthesis PPC Synthetase, Pantothenate Kinase
Glycolipid Synthesis Ppyr Decarboxylase, LPG1L
Cell Redox Homeostasis
Oxidoreductase Activity Adrenodoxin reductase, monooxygenase, quinone-oxidoreductase, Cyt P450, Cyt b5
reductase, G3P dh
Glutathion Metabolism 5-Oxoprolinase
Cytoskeleton Tubulin-Tyr ligase, -tubulin, MAP Gb4
Flagellum Organization Paraflagellar rod protein, flagellar transport protein, dynein heavy chain
Kinases and Phosphatases
Kinases Rac Ser/Thr kinase, Ser/Thr-protein kinase, protein kinase, Ser/Arg-rich protein kinase,
cdc2-related kinase
Phosphatases dual specificity protein phosphatase, TFIIF-stimulated CTD phosphatase, Ser/Thr-protein
phosphatase 2A
Other vATPase subc, TM9SF, GTP-binding protein, Tc40 Antigen, RHS protein, IFT81, kinesin
divergent sequence, P-glycoprotein, WD40 repeat protein, Zn Finger proteins,
calmodulin, AcOrn deacetylase, TAT
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cases most of the protein is present in the nucleus. The
nonconjugatable forms of TcSUMO show a uniform distribu-
tion throughout the parasite cell.
Parasites transfected with construct 1 (full TcSUMO pre-
cursor) were used for the sample because they must follow
the complete SUMOylation pathway, including proteolytic
processing, activation and conjugation to targets, and so they
are very similar to the wild type parasites undergoing natural
SUMOylation. The mutant constructs 2 and 4 were not used
as mock treatments, because in both cases a small amount of
conjugates was formed, despite the mutations. This was not
unexpected, because it has been reported that Saccharo-
myces cerevisiae mutants with the SUMO gene deleted
(which are not viable) can be complemented with the GxA
mutant, analogous to construct 2, giving a petite phenotype
(38). Moreover, Western blot analysis of the mutant proteins
GxA in both, yeast and human SUMO isoforms, presented a
low degree of processing and conjugation to targets (31, 38,
45). A low formation of conjugates is not important when
working in a small scale, as in Fig. 3C, but it certainly would
be important when scaling up in order to obtain a compa-
rable control, thus invalidating the mock treatment. A mock
purification from a wild-type cell line was performed as a
negative control.
Here we developed a purification scheme with two TAP
steps to reduce the number of nonspecific binding proteins.
Although this allowed us to obtain a fraction enriched in
SUMOylated proteins (n  236) identified by 2D LC-MS/MS,
we still found a significant number of nonspecific binders or
interactors (n  2,450). Despite TAP being the current ap-
proach of choice for reducing nonspecific interactions, thus
far there is no data to set a normal level of contaminants in this
type of experiment, even if two-step purification is allegedly
considered “specific ” in general. To further address this
issue, we processed our data using the same criteria as
described by Wohlschlegel et al. (12), which validated SUMO-
ylated targets in S. cerevisae. Accordingly, we considered as
potential SUMOylated proteins only those identified with at
least two peptides and not present in the mock sample. For
this analysis we used only one of our replicates (mock 2
versus test 2), because the data reported by Wohlschlegel et
al. (12) was based on a single experiment. With these criteria,
we identified 2083 proteins, of which 851 (40.9%) are present
in the test but not in the mock sample (supplemental Fig. S4).
Thus, our data has similar fold of enrichment compared with
the data reported by Wohlschlegel et al. (12) (271 (38.5%),
SUMOylated proteins out of 704 identified proteins). Unfortu-
nately, we were unable to use similar criteria as described by
Galisson et al. (41) for SUMOylated proteins of human cells,
because their approach employed a quantification based on
the intensity of MS1 scans. Moreover, in a recent publication
by Westman et al. (42) only 25 (4.2%) out of 590 identified
proteins were validated as SUMO targets in a nucleolar frac-
tion of human cells. Therefore, in general the data described
in the present study is in fair agreement with those described
in the literature (12, 42).
In good agreement with the nuclear localization of the HA-
tagged SUMO construct, many of the SUMOylated proteins
detected in our proteomic analysis are predicted to perform
their functions within the nucleus, including DNA replication
and repair, chromatin remodeling, pre-mRNA splicing, rRNA
processing, ribosome biogenesis, and nuclear transport. Rep-
lication and repair of DNA is a well-studied biological process
regulated by SUMOylation. In this category, we identified
three putative components of the replication fork: DNA pol 	,
PCNA and RFC; and two proteins likely to participate in the
mechanism of DNA repair, namely, DNA pol 
 and RAD51 (46).
Two of these proteins have already been validated; PCNA is a
well conserved SUMO target in several organisms and RFC
was recently demonstrated to be SUMOylated in Drosophila.
(15). In addition, PCNA is one example of SUMO and ubiquitin
crosstalk, because both molecules modify the same lysine
residue but confer opposite properties (47). Other levels of
SUMO and Ub crosstalk exist, involving two components of
the ubiquitination system: the E3 ubiquitin protein ligases and
the deubiquitinating enzymes (DUBs). In both cases the en-
zymes have SUMO-interacting motifs (SIM) (48, 49) stabilizing
their binding to SUMO and facilitating subsequent conjuga-
FIG. 5. Validation of metacaspase-3 as a SUMOylation target in
vivo. A stable cell line of epimastigotes expressing T. cruzi meta-
caspase-3 tagged with a 3  FLAG (TcMCA3–3FLAG) was grown in
the presence of tetracycline for 60 h before cell lysate was prepared.
TcMCA3–3FLAG protein was purified by immunoaffinity chroma-
tography using anti-FLAG M2-agarose affinity gel. Eluate was
electrophoresed on 7.5% SDS-PAGE, transferred to nitrocellulose
membranes and probed with either anti-FLAG (left) or anti-SUMO
(right) antibodies. Protein bands corresponding to metacaspase and
SUMOylated metacaspase-3 are shown with an empty or filled
arrowhead.
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tion (50). In the former case, the interaction promotes a co-
valent linkage of one Ubiquitin molecule to the end of the
polySUMO chain of conjugated protein, driving it to degrada-
tion (51, 52). In the latter, a specific DUB named USP25 is
SUMOylated at a Lys residue embedded in a region critical for
Ub recognition, thus decreasing its isopeptidase activity (53).
Interestingly, we also detected homologs to E3 ligases and
DUBs in our proteomic study.
It has been previously reported that diverse chromatin-
modifying enzymes and chromatin-associated proteins are
the effectors of SUMO-dependent changes in chromatin
structure and gene expression in yeast and mammalian
cells (54). In our list of potential SUMO substrates we de-
tected the thymidine-hydroxylase JBP-1, a nucleosome as-
sembly protein and a putative GC5N histone acetyltrans-
ferase. Because RNA polymerase II transcription seems to
be constitutive in Trypanosomatids, with promoters and
transcription factors likely to be absent in the genome (55),
the presence of proteins involved in DNA modification and
chromatin organization in our SUMO targets’ data set rep-
resents a very interesting finding and reflects a potential role
for SUMO in determining chromatin conformation and tran-
scriptional activity.
We also identified the poly(A)-binding protein PABP-1, as
well as other putative RNA recognition motif-containing pro-
teins such as TRRM1 and PUF6 in our proteomic analysis,
meaning that SUMO could also play a role at a post-transcrip-
tional level regulating mRNA abundance. Another unique fea-
ture of all Trypanosomatids is the fact that transcription is
polycistronic and a trans-splicing event is needed in order to
produce mature mRNAs (56). We believe SUMO could partic-
ipate as well in this process, because several splicing factors
(e.g. hnRNPH, U5 snRNP-specific 40 kDa protein, and pseu-
doU Synthase I) were found in our analysis.
It has been noticed in Trypanosomatids that there is a
very weak correlation between mRNA abundance and pro-
tein expression (57–59), suggesting an important regulation
step at the translational level and/or at the level of protein
degradation. Very recently, SUMO has been implicated in a
novel fundamental regulatory mechanism of protein synthe-
sis. SUMOylation of mammalian translation initiation factor
4 (eIF4E) has been shown to promote the formation of the
active translation initiation complex (60) in a conjugation
reaction that depends on the E3 ligase activity of the histone
deacetylase (HDAC2) (61). We were not able to detect T.
cruzi eIF4E as a SUMO target in our proteomic approach;
however, other components of the translation initiation
complex (i.e. eIF4A (orthologous to LmeIF4A2), SUI-1 (cor-
responding to eIF-3 small subunit), and eIF-2/eIF-5) were
present in our study.
Another distinctive aspect of Trypanosomatids is the exten-
sive editing of the RNA that takes place in the parasite’s single
mitochondrion (62). We found proteins that are known to be
involved in the editing mechanism like the RNA editing en-
doribonuclease and ligase, and the oligoU-binding protein.
The fact that a mitochondrial protein could be a SUMO sub-
strate has been investigated lately, and very recently a spe-
cific E3 ligase catalyzing specific SUMO conjugation to mito-
chondrial targets has been identified (4).
A large number of proteins that are structural constituents
of ribosomes or are potentially involved in ribosome biogen-
esis were found in our proteomic experiment. This is not
surprising because many proteomic studies propose ribo-
somal particles and trans-acting factors as potential SUMO
substrates. Furthermore, it has been recently documented
that preribosome assembly and nuclear export is functionally
linked to the SUMO pathway in yeasts. Eighteen factors in-
volved in ribosome biogenesis were validated as bona fide
SUMO targets (63). Diverse aminoacyl-tRNA synthetases
were detected in our list of potential SUMO targets. In Dro-
sophila glutamyl-prolyl-tRNA synthetase and methionyl-tRNA
synthetase were demonstrated to be conjugated with SUMO
in vivo, and a potential role for this modification in increasing
the traffic of tRNAs from the nucleus to the ribosomes was
suggested (64).
An outstanding finding in our proteomic analysis is the
occurrence of metacaspase-3 among the potential SUMO
targets. We have confirmed that at least one metacaspase-3
isoform is conjugated to SUMO in vivo, even under conditions
when SUMO is expressed at endogenous levels. The band
with the lower mobility shows an apparent molecular mass,
which suggests that two molecules of TcSUMO have been
covalently linked, but we cannot tell if the second is linked to
the first, or if both are covalently bound to different sites of the
target. To our knowledge, this is the first metacaspase being
post-translationally modified with SUMO. Metacaspases are
distant caspase relatives present in plant, fungi, and protozoa
(65). This novel family of peptidases shares with caspases a
common fold but displays radically different substrate spec-
ificity and it is not clear whether their members play an anal-
ogous role in programmed cell death in nonmetazoan orga-
nisms (66). Caspase-2 and -7 have been reported to be
SUMOylated (67, 68), and a detailed study on caspase-8
elegantly demonstrated that SUMOylation of this protein is
determinant for its nuclear localization (69). Thus, modulation
of metacaspase subcellular localization by SUMO conjugation
is an intriguing possibility. However we cannot rule out that
SUMOylation could be affecting the proteolytic activity of
metacaspase, as it was shown to be the case for another
peptidase, calpain-2 (70).
The fact SUMO resulted essential for T. brucei viability (18,
19) reflects that the SUMOylation system is also important in
these early divergent eukaryotes, and emphasizes the rele-
vance of studying the proteins modified by SUMO. According
to the conditions in which the purification of SUMOylated
proteins is performed, a different kind of information can be
extracted from a proteomic study. If strong denaturating con-
ditions are used, a more refined information about covalent
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target is obtained. However, if it is performed under native
conditions, as in the present work, the data may include
proteins that directly or indirectly interact with SUMOylated
targets (15, 44). This is the first large-scale proteomic study
aimed to identify SUMO interactors in trypanosomatids per-
formed under native conditions. We found a broad spectrum
of biological processes potentially influenced by SUMO, some
of them representing general cellular processes whereas
some others are distinctive of trypanosomatids. Unraveling
the role of SUMOylation in these processes requires a more
detailed study on individual targets and on how SUMO could
affect their subcellular localization, activity or interactions.
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